Search Team

Search by Last Name
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Fish Litigation Blog

Welcome to the Fish & Richardson litigation blog, a community site where our intellectual property, commercial, and white collar litigators share information on nationwide litigation developments and trends. Join the conversation!

Fish Litigation Blog
Filter blogs by
Webinars

Fish Litigation Blog

The depth and breadth of Fish’s litigation practice is constantly expanding to fit the needs of our clients and the realities of the economic, business, and technological challenges they face. Our litigation blog reflects the full expanse of our litigation practice. Among other things, we discuss: developments in patent and trademark litigation, intricacies associated with ITC proceeding, Federal Circuit summaries and Supreme Court decisions, how courts are handling NPE litigation, various manifestations of the America Invents Act (AIA), commercial and business litigation matters, the Delaware Court of Chancery, and white collar defense and government investigation issues.

q&a 2016

Welcome to the conversation!

 


IP Litigation, Life Sciences
August 25, 2016
Court Invalidates Janssen Remicade® Patent for Double Patenting; Celltrion Seeks Speedy Appeal
Authors: Rachel Bandli, Jenny Shmuel, Ph.D.
IP Litigation, Federal Circuit
August 16, 2016
Federal Circuit Once Again Finds That a Functional Claim Term is Indefinite Even Without the Use of “Means.”
Author: David B. Conrad
IP Litigation, Federal Circuit, Life Sciences
August 15, 2016
Federal Circuit Denies Motion to Dismiss Appeal of BPCIA-Related Discovery Order
Author: Jenny Shmuel, Ph.D.
IP Litigation, Life Sciences
August 11, 2016
Apotex Takes Aim at Amgen Patent in IPR Petition After Being Sued Under the BPCIA
Author: Kevin DeJong
IP Litigation, Life Sciences
August 8, 2016
Amgen Can Enforce Notice of Commercial Marketing for Epogen® Biosimilar
Authors: Jenny Shmuel, Ph.D., Tasha M. Francis, Ph.D.
IP Litigation, Federal Circuit
July 27, 2016
Federal Circuit Explains Burden Shifting in IPRs
Author: John A. Dragseth
IP Litigation, Life Sciences
July 26, 2016
Amgen DJ to Compel Patent Dance Dismissed
Authors: Jenny Shmuel, Ph.D., Tasha M. Francis, Ph.D.
IP Litigation, Life Sciences
July 25, 2016
Can Reference Product Sponsor Forfeit Right To Sue Under BPCIA?
Authors: Brian D. Coggio, Ron Vogel
IP Litigation, Life Sciences
July 14, 2016
Fall-Out from the Federal Circuit’s Decision in Amgen v. Apotex
Authors: Jenny Shmuel, Ph.D., Tasha M. Francis, Ph.D., Alex Pechette
IP Litigation
July 11, 2016
Notice of Commercialization Is Only Effective After FDA-Approval Regardless of Whether Parties Dance
Authors: Jenny Shmuel, Ph.D., Tasha M. Francis, Ph.D.
IP Litigation
June 24, 2016
Patent Litigation for the Non-Specialist: How it Works and What to Expect
Authors: Jolynn M. Lussier, Adam Kessel, Lawrence K. Kolodney
load more posts

Stay current with Fish Sign up for our Newsletter